About Correlagen
Correlagen is a Healthcare company based in Waltham (United States) founded in 2000, and was acquired by LabCorp in January 2010. PCR and sequencing-based genetic tests are provided for clinical labs. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2000 and based in Waltham, United States, genetic testing services are offered by the company in the healthcare sector. PCR amplification and DNA sequencing on an automated platform form the basis of these tests, which support diagnoses in cardiology, gastroenterology, hematology, immunology, metabolic disorders, nephrology, oncology, ophthalmology, pulmonology, and urology. Services are available to private practitioners and researchers at academic institutions.
- Headquarters Waltham, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website correlagen.com
- Social LinkedIn
- Acquired by LabCorp (Jan 2010)
Investors in Correlagen
Correlagen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LabCorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of laboratory tests for physicians | 1969 | labcorp.com | Burlington, United States |
Investor details for Correlagen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Correlagen
2 dated milestones of Correlagen across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Correlagen is founded.
- Exit Acquired by LabCorp.
Competitors of Correlagen
Correlagen has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. |
Detailed competitors of Correlagen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Correlagen
Websites that share an audience with Correlagen (correlagen.com).
Websites whose visitors overlap most with Correlagen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| recombine.com | 88% | View details | |||
| invitae.com | 72% | 439.4K | #95,124 | View details | |
| ambrygen.com | 71% | 189.2K | #206,714 | View details | |
| gbhealthwatch.com | 54% | 19.9K | #1,576,580 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Correlagen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Correlagen
Correlagen was founded in 2000.
Correlagen is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Founded in 2000 and based in Waltham, United States, genetic testing services are offered by the company in the healthcare sector. PCR amplification and DNA sequencing on an automated platform form the basis of these tests, which support diagnoses in cardiology, gastroenterology, hematology, immunology, metabolic disorders, nephrology, oncology, ophthalmology, pulmonology, and urology. Services are available to private practitioners and researchers at academic institutions.
Correlagen's top competitors include Poseida Therapeutics, Denali Therapeutics and Castle Biosciences.
Correlagen has 1 investor. Key investors include LabCorp.
Yes. Correlagen was acquired by LabCorp in January 2010.